Watchlist

Watchlist
Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Inc. (APVO)
3 Things In Biotech You Should Learn Today: November 29, 2017
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Bristol-Myers Squibb preps a new assault on kidney cancer in Europe Company: Bristol-Myer…
Aptevo to launch mid-stage study of otlertuzumab in PTCL this quarter; shares ahead 1%
Aptevo Therapeutics ( APVO +1% ) will launch an open-label proof-of-concept Phase 2 clinical trial this quarter evaluating monospecific antibody candidate otlertuzumab, combined with the chemo agent bendamustine, for the treatment of peripheral T-cell lymphoma (PTCL), a new indication. T…
Planned equity offering roundup - healthcare
Recent SEC filings for anticipated equity offerings: More news on: Aptevo Therapeutics Inc., Healthcare stocks news, Read more …
Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Neurocrine Biosciences Today we will d…
Aptevo Therapeutics reports Q3 results
Aptevo Therapeutics (NASDAQ: APVO ): Q3 EPS of -$0.14 More news on: Aptevo Therapeutics Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more …
Aptevo Therapeutics: Slowly Grinding Higher
In my last article about Aptevo Therapeutics ( APVO ), I said the stock was likely worth at least $5 a share . Please note that on the same day I wrote that article, APVO closed at $2.11, with a high of about $2.45. After that folks, it was all downhill from there. APVO continued to drift l…
After Hours Gainers / Losers
Top gainers, as of 5.25 p.m.: ITEK +3.8% . CDNA +2.49% . FLXN +1.9% . ACRX +1.9% . SECO +1.9% . More news on: Inotek Pharmaceuticals, CareDx, Flexion Therapeutics, Inc., Stocks on the move, Read more …
After Hours Gainers / Losers
Top gainers, as of 5.25 p.m.: SNCR +19.4% . ADMS +4.8% . APVO +3.7% . YUMC +3.4% . ATTO +1.8% . More news on: Synchronoss Technologies, Inc., Adamas Pharmaceuticals, Inc., Aptevo Therapeutics Inc., Stocks on the move, Read more …
Midday Gainers / Losers
Gainers: ONVI +96% . MNKD +40% . APVO +36% . GNCA +35% . CDNA +32% . ITEK +31% . NETE +29% . ABAC +28% . XBIO +22% . CBAK +21% . More news on: Onvia, Inc., MannKind Corporation, Aptevo Therapeutics Inc., Stocks on the move, Read more …
Premarket Gainers as of 9:05 am
APVO +25% on positive analyst action. More news on: Aptevo Therapeutics Inc., CareDx, Cerus Corporation, Stocks on the move, Read more …
Premarket analyst action - healthcare
Gilead Sciences (NASDAQ: GILD ) initiated with Market Perform rating by Oppenheimer. More news on: Gilead Sciences, Inc., FibroGen, Akebia Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more …
Aptevo Therapeutics Inc. (APVO)